{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:45:51Z","timestamp":1789764351033,"version":"4.0.1"},"reference-count":192,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:00:00Z","timestamp":1702771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2019-1661"],"award-info":[{"award-number":["075-15-2019-1661"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The rate of neurodegenerative disorders (NDDs) is rising rapidly as the world\u2019s population ages. Conditions such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and dementia are becoming more prevalent and are now the fourth leading cause of death, following heart disease, cancer, and stroke. Although modern diagnostic techniques for detecting NDDs are varied, scientists are continuously seeking new and improved methods to enable early and precise detection. In addition to that, the present treatment options are limited to symptomatic therapy, which is effective in reducing the progression of neurodegeneration but lacks the ability to target the root cause\u2014progressive loss of neuronal functioning. As a result, medical researchers continue to explore new treatments for these conditions. Here, we present a comprehensive summary of the key features of NDDs and an overview of the underlying mechanisms of neuroimmune dysfunction. Additionally, we dive into the cutting-edge treatment options that gene therapy provides in the quest to treat these disorders.<\/jats:p>","DOI":"10.3390\/biomedicines11123333","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T05:41:35Z","timestamp":1702878095000},"page":"3333","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Advances of Genome Editing with CRISPR\/Cas9 in Neurodegeneration: The Right Path towards Therapy"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4902-9789","authenticated-orcid":false,"given":"Aleksandr","family":"Klinkovskij","sequence":"first","affiliation":[{"name":"Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Centre \u201cDigital Biodesign and Personalized Healthcare\u201d, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-3048","authenticated-orcid":false,"given":"Mikhail","family":"Shepelev","sequence":"additional","affiliation":[{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 34\/5 Vavilova Str., Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Isaakyan","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), 8 Trubetskaya Str., Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-8571","authenticated-orcid":false,"given":"Denis","family":"Aniskin","sequence":"additional","affiliation":[{"name":"Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Centre \u201cDigital Biodesign and Personalized Healthcare\u201d, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-0363","authenticated-orcid":false,"given":"Ilya","family":"Ulasov","sequence":"additional","affiliation":[{"name":"Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Centre \u201cDigital Biodesign and Personalized Healthcare\u201d, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,17]]},"reference":[{"key":"ref_1","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022). Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 7, e105\u2013e125."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of Neurodegenerative Diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-Tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3233\/JAD-180865","article-title":"Ethical Issues in the Treatment of Late-Stage Alzheimer\u2019s Disease","volume":"68","author":"Watt","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_5","first-page":"3234","article-title":"Longitudinal Plasma P-Tau217 Is Increased in Early Stages of Alzheimer\u2019s Disease","volume":"143","author":"Janelidze","year":"2021","journal-title":"Brain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2528\/PIER13121310","article-title":"Classification of Alzheimer Disease Based on Structural Magnetic Resonance Imaging by Kernel Support Vector Machine Decision Tree","volume":"144","author":"Zhang","year":"2014","journal-title":"Prog. Electromagn. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET Imaging in Neurodegenerative Tauopathies\u2014Still a Challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neubiorev.2020.10.013","article-title":"Effectiveness of Sorting Tests for Detecting Cognitive Decline in Older Adults with Dementia and Other Common Neurodegenerative Disorders: A Meta-Analysis","volume":"120","author":"Foran","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bmb\/ldab016","article-title":"The Promise of Artificial Intelligence: A Review of the Opportunities and Challenges of Artificial Intelligence in Healthcare","volume":"139","author":"Aung","year":"2021","journal-title":"Br. Med. Bull."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Termine, A., Fabrizio, C., Strafella, C., Caputo, V., Petrosini, L., Caltagirone, C., Giardina, E., and Cascella, R. (2021). Multi-Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data through Artificial Intelligence. J. Pers. Med., 11.","DOI":"10.3390\/jpm11040280"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.3390\/molecules19056891","article-title":"Circulating miRNAs as Biomarkers for Neurodegenerative Disorders","volume":"19","author":"Grasso","year":"2014","journal-title":"Molecules"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wolinsky, F.D., Mahncke, H.W., Kosinski, M., Unverzagt, F.W., Smith, D.M., Jones, R.N., Stoddard, A., and Tennstedt, S.L. (2009). The ACTIVE Cognitive Training Trial and Predicted Medical Expenditures. BMC Health Serv. Res., 9.","DOI":"10.1186\/1472-6963-9-109"},{"key":"ref_13","unstructured":"(2017). Parkinson\u2019s Disease in Adults: Diagnosis and Management, National Institute for Health and Care Excellence (NICE). National Institute for Health and Care Excellence: Guidelines."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3233\/JAD-160810","article-title":"Cognitive Training Interventions for Patients with Alzheimer\u2019s Disease: A Systematic Review","volume":"56","author":"Kallio","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neubiorev.2021.05.025","article-title":"Effects of Physical Exercise on Plasma Brain-Derived Neurotrophic Factor in Neurodegenerative Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"128","author":"Valenzuela","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: From Genes to Mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging Mechanisms in Als and FTD: Disrupted RNA and Protein Homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/nm.4001","article-title":"Proteostasis and Aging","volume":"21","author":"Kaushik","year":"2015","journal-title":"Nat. Med."},{"key":"ref_19","first-page":"168","article-title":"Ransohoff2016","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative Diseases and Oxidatives Stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER Stress and the Unfolded Protein Response in Neurodegeneration","volume":"13","author":"Hetz","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1093\/hmg\/ddy139","article-title":"Neurodegenerative Diseases Have Genetic Hallmarks of Autoinflammatory Disease","volume":"27","author":"Richards","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Copp\u00e9, J.P., Patil, C.K., Rodier, F., Sun, Y., Mu\u00f1oz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.Y., and Campisi, J. (2008). Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the P53 Tumor Suppressor. PLoS Biol., 6.","DOI":"10.1371\/journal.pbio.0060301"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of Senescent Glial Cells Prevents Tau-Dependent Pathology and Cognitive Decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of P16 Ink4a-Positive Senescent Cells Delays Ageing-Associated Disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: A New Immune\u2013Metabolic Viewpoint for Age-Related Diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.it.2020.02.002","article-title":"Neuroimmune Connections in Aging and Neurodegenerative Diseases","volume":"41","author":"Scheiblich","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_28","first-page":"4","article-title":"The Microglial-Motoneuron Dialogue in ALS","volume":"30","author":"Appel","year":"2011","journal-title":"Acta Myol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Phatnani, H., and Maniatis, T. (2015). Astrocytes in Neurodegenerative Disease. Cold Spring Harb. Perspect. Biol., 7.","DOI":"10.1101\/cshperspect.a020628"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1083159","DOI":"10.3389\/fncel.2022.1083159","article-title":"Functions and Dysfunctions of Oligodendrocytes in Neurodegenerative Diseases","volume":"16","author":"Han","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System during Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Dadwal, S., and Heneka, M.T. (2023). Microglia Heterogeneity in Health and Disease. FEBS Open Bio.","DOI":"10.1002\/2211-5463.13735"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-Associated Molecular Patterns in Inflammatory Diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate Immune Activation in Neurodegenerative Disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Poupot, R., Bergozza, D., and Fruchon, S. (2018). Nanoparticle-Based Strategies to Treat Neuro-Inflammation. Materials, 11.","DOI":"10.3390\/ma11020270"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2014.01.001","article-title":"Pattern Recognition Receptors and Central Nervous System Repair","volume":"258","author":"Kigerl","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27392","DOI":"10.1074\/jbc.M702887200","article-title":"CD36 Signals to the Actin Cytoskeleton and Regulates Microglial Migration via a p130Cas Complex","volume":"282","author":"Stuart","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 Ligands Promote Sterile Inflammation through Assembly of a Toll-like Receptor 4 and 6 Heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","article-title":"CD36, a Class B Scavenger Receptor, Is Expressed on Microglia in Alzheimer\u2019s Disease Brains and Can Mediate Production of Reactive Oxygen Species in Response to \u03b2-Amyloid Fibrils","volume":"160","author":"Coraci","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 Mediates the Innate Host Response to \u03b2-Amyloid","volume":"197","author":"Moore","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Spinrad","year":"2017","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fncel.2020.00078","article-title":"Sen Dissecting the Dual Role of the Glial Scar and Scar-Forming Astrocytes in Spinal Cord Injury","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive Astrocyte Nomenclature, Definitions, and Future Directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41593-017-0033-9","article-title":"The Diversity and Disparity of the Glial Scar","volume":"21","author":"Adams","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"594170","DOI":"10.3389\/fncel.2020.594170","article-title":"Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Fields, R.D. (2012). Glial Cells, Elsevier Inc.. [2nd ed.].","DOI":"10.1016\/B978-0-12-375000-6.00181-6"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","article-title":"Myelination of the Nervous System: Mechanisms and Functions","volume":"30","author":"Nave","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16480","DOI":"10.1073\/pnas.1117943109","article-title":"Prolonged Myelination in Human Neocortical Evolution","volume":"109","author":"Miller","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Duncan, G.J., Simkins, T.J., and Emery, B. (2021). Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.653101"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.31887\/dcns.2018.20.4\/amot","article-title":"An Emerging Role of Dysfunctional Axon-Oligodendrocyte Coupling in Neurodegenerative Diseases","volume":"20","author":"Mot","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","article-title":"Oligodendroglia Metabolically Support Axons and Contribute to Neurodegeneration","volume":"487","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple Sclerosis and Myelin Basic Protein: Insights into Protein Disorder and Disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"654284","DOI":"10.3389\/fncel.2021.654284","article-title":"Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?","volume":"15","author":"Psenicka","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fncel.2020.00032","article-title":"Filling the Gaps\u2014A Call for Comprehensive Analysis of Extracellular Matrix of the Glial Scar in Region- and Injury-Specific Contexts","volume":"14","author":"Kjell","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnmol.2020.00148","article-title":"Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases","volume":"13","author":"Rittiner","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/jvi.71.9.6641-6649.1997","article-title":"Highly Efficient and Sustained Gene Transfer in Adult Neurons with a Lentivirus Vector","volume":"71","author":"Naldini","year":"1997","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jnr.10719","article-title":"Targeted Transgene Expression in Rat Brain Using Lentiviral Vectors","volume":"73","author":"Jakobsson","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","article-title":"Multicistronic Lentiviral Vector-Mediated Striatal Gene Transfer of Aromatic L-Amino Acid Decarboxylase, Tyrosine Hydroxylase, and GTP Cyclohydrolase I Induces Sustained Transgene Expression, Dopamine Production, and Functional Improvement in a Rat Model","volume":"22","author":"Azzouz","year":"2002","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/85454","article-title":"In Vivo Gene Therapy of Metachromatic Leukodystrophy by Lentiviral Vectors: Correction of Neuropathology and Protection against Learning Impairments in Affected Mice","volume":"7","author":"Consiglio","year":"2001","journal-title":"Nat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"18786","DOI":"10.1073\/pnas.0905859106","article-title":"Epigenetic Activation of Unintegrated HIV-1 Genomes by Gut-Associated Short Chain Fatty Acids and Its Implications for HIV Infection","volume":"106","author":"Kantor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/mt.2008.199","article-title":"A Large U3 Deletion Causes Increased in Vivo Expression from a Nonintegrating Lentiviral Vector","volume":"16","author":"Bayer","year":"2008","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical Use of Lentiviral Vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41434-020-00193-y","article-title":"The Stability of Envelope-Pseudotyped Lentiviral Vectors","volume":"28","author":"Dautzenberg","year":"2021","journal-title":"Gene Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-800149-3.00003-2","article-title":"Methods for Gene Transfer to the Central Nervous System","volume":"87","author":"Kantor","year":"2014","journal-title":"Adv. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the Tropism of Lentiviral Vectors through Pseudotyping","volume":"5","author":"Cronin","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/mt.2014.174","article-title":"Lentiviral Vector-Based Insertional Mutagenesis Identifies Genes Involved in the Resistance to Targeted Anticancer Therapies","volume":"22","author":"Ranzani","year":"2014","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","article-title":"Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR\/Cas9-Mediated Gene Editing","volume":"5","author":"Ortinski","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2009.122","article-title":"Integration-Deficient Lentiviral Vectors: A Slow Coming of Age","volume":"17","author":"Wanisch","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Li, M., and Snider, B.J. (2018). Chapter 1\u2014Gene Therapy Methods and Their Applications in Neurological Disorders, Academic Press.","DOI":"10.1016\/B978-0-12-809813-4.00001-6"},{"key":"ref_73","unstructured":"(2023, November 01). Gene Therapy: The Age of AAV. Available online: https:\/\/wyss.harvard.edu\/news\/gene-therapy-the-age-of-aav\/."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/hum.2020.069","article-title":"Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction","volume":"31","author":"Maurer","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_75","first-page":"317","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene Therapy Using Adeno-Associated Virus Vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41417-021-00413-6","article-title":"Safety of Adeno-Associated Virus-Based Vector-Mediated Gene Therapy\u2014Impact of Vector Dose","volume":"29","author":"Maurya","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Large, E.E., Silveria, M.A., Zane, G.M., Weerakoon, O., and Chapman, M.S. (2021). Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry. Viruses, 13.","DOI":"10.3390\/v13071336"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/fvl.10.48","article-title":"Adeno-Associated Virus: A Key to the Human Genome?","volume":"5","author":"Henckaerts","year":"2010","journal-title":"Future Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for Efficient Noninvasive Gene Delivery to the Central and Peripheral Nervous Systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_81","first-page":"482","article-title":"Clinical Trials in Neurological Disorders Using AAV Vectors: Promises and Challenges","volume":"6","author":"Mandel","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","article-title":"Transduction Characteristics of Adeno-Associated Virus Vectors Expressing Cap Serotypes 7, 8, 9, and Rh10 in the Mouse Brain","volume":"13","author":"Cearley","year":"2006","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous Administration of Self-Complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/156652309789753383","article-title":"AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS","volume":"9","author":"Hester","year":"2009","journal-title":"Curr. Gene Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS Gene Delivery and Evasion of Anti-AAV-Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature.2017.22819","article-title":"FDA Advisers Back Gene Therapy for Rare Form of Blindness","volume":"550","author":"Ledford","year":"2017","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"RETRACTED ARTICLE: Rescue of the Spinal Muscular Atrophy Phenotype in a Mouse Model by Early Postnatal Delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV Vectors Applied to the Treatment of CNS Disorders: Clinical Status and Challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of Adeno-Associated Virus (AAV) and Recombinant AAV Vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High Levels of AAV Vector Integration into CRISPR-Induced DNA Breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The Promise and Challenge of Therapeutic Genome Editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1093\/nar\/gkaa208","article-title":"PAM Recognition by Miniature CRISPR-Cas12f Nucleases Triggers Programmable Double-Stranded DNA Target Cleavage","volume":"48","author":"Karvelis","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aav4294","article-title":"Programmed DNA Destruction by Miniature CRISPR-Cas14 Enzymes","volume":"362","author":"Harrington","year":"2018","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Kim, D.Y., Chung, Y., Lee, Y., Jeong, D., Park, K.-H., Chin, H.J., Lee, J.M., Park, S., Ko, S., and Ko, J.-H. (2023). Author Correction: Hypercompact Adenine Base Editors Based on a Cas12f Variant Guided by Engineered RNA. Nat. Chem. Biol., 19.","DOI":"10.1038\/s41589-023-01258-w"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41587-021-01009-z","article-title":"Efficient CRISPR Editing with a Hypercompact Cas12f1 and Engineered Guide RNAs Delivered by Adeno-Associated Virus","volume":"40","author":"Kim","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0301-0082(98)00028-8","article-title":"Adenovirus in the Brain: Recent Advances of Gene Therapy for Neurodegenerative Diseases","volume":"55","author":"Barkats","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Federici, T., Riley, J., and Boulis, N. (2009). Gene-Based Neuromodulation, Elsevier Ltd.","DOI":"10.1016\/B978-0-12-374248-3.00014-8"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/jvi.29.3.1056-1064.1979","article-title":"Transforming Region of Group A, B, and C Adenoviruses: DNA Homology Studies with Twenty-Nine Human Adenovirus Serotypes","volume":"29","author":"Mackey","year":"1979","journal-title":"J. Virol."},{"key":"ref_99","unstructured":"Kaspar, B.K. (2009). Encyclopedia of Neuroscience, Elsevier."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/v2091886","article-title":"Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives","volume":"2","author":"Vetrini","year":"2010","journal-title":"Viruses"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Atasheva, S., and Shayakhmetov, D.M. (2022). Cytokine Responses to Adenovirus and Adenovirus Vectors. Viruses, 14.","DOI":"10.3390\/v14050888"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.gt.3302048","article-title":"Inflammation and Adaptive Immune Responses to Adenoviral Vectors Injected into the Brain: Peculiarities, Mechanisms, and Consequences","volume":"10","author":"Lowenstein","year":"2003","journal-title":"Gene Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene Therapy for Neurodegenerative Disorders: Advances, Insights and Prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/genetics\/161.3.1169","article-title":"Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases","volume":"161","author":"Bibikova","year":"2002","journal-title":"Genetics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1073\/pnas.1009424107","article-title":"Gene Targeting by Homologous Recombination in Mouse Zygotes Mediated by Zinc-Finger Nucleases","volume":"107","author":"Meyer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE Nuclease Architecture for Efficient Genome Editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1178811","article-title":"Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.ggedit.2021.100007","article-title":"TALE and TALEN Genome Editing Technologies","volume":"2","author":"Becker","year":"2021","journal-title":"Gene Genome Ed."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-Guided Human Genome Engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex Genome Engineering Using CRISPR\/Cas Systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.1179555","article-title":"CRISPR\/Cas, the Immune System of Bacteria and Archaea","volume":"327","author":"Horvath","year":"2010","journal-title":"Science"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary Classification of CRISPR-Cas Systems: A Burst of Class 2 and Derived Variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00412-018-0677-6","article-title":"Making Ends Meet: Targeted Integration of DNA Fragments by Genome Editing","volume":"127","author":"Yamamoto","year":"2018","journal-title":"Chromosoma"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","article-title":"CRISPR-Based Genome Editing through the Lens of DNA Repair","volume":"82","author":"Nambiar","year":"2022","journal-title":"Mol. Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","article-title":"CRISPR\/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer\u2019s Disease","volume":"11","author":"Zaborowski","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer\u2019s Disease-A Narrative Review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC Locus with CRISPR\/Cas9 Enhances Tumour Rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Ustiugova, A.S., Ekaterina, D.M., Nataliya, M.V., Alexey, D.A., Dmitry, K.V., and Marina, A.A. (2023). CRISPR\/Cas9 Genome Editing Demonstrates Functionality of the Autoimmunity-Associated SNP Rs12946510. Biochim. Biophys. Acta Mol. Basis Dis., 1869.","DOI":"10.1016\/j.bbadis.2022.166599"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome Editing with CRISPR-Cas Nucleases, Base Editors, Transposases and Prime Editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: A Review of the Challenges and Approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of Chromosome Loss in Clinical CRISPR-Cas9-Engineered T Cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04470-1","article-title":"Structural Basis for Mismatch Surveillance by CRISPR-Cas9","volume":"603","author":"Bravo","year":"2022","journal-title":"Nature"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","article-title":"Directed Evolution of CRISPR-Cas9 to Increase Its Specificity","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A High-Fidelity Cas9 Mutant Delivered as a Ribonucleoprotein Complex Enables Efficient Gene Editing in Human Hematopoietic Stem and Progenitor Cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gendis.2014.09.004","article-title":"The Versatile Functions of Sox9 in Development, Stem Cells, and Human Diseases","volume":"1","author":"Jo","year":"2014","journal-title":"Genes. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuron.2016.09.026","article-title":"The Calcium Channel Subunit Alpha2delta2 Suppresses Axon Regeneration in the Adult CNS","volume":"92","author":"Tedeschi","year":"2016","journal-title":"Neuron"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1523\/JNEUROSCI.3199-16.2017","article-title":"SOX9 Is an Astrocyte-Specific Nuclear Marker in the Adult Brain Outside the Neurogenic Regions","volume":"37","author":"Sun","year":"2017","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/glia.22424","article-title":"Conditional Sox9 Ablation Reduces Chondroitin Sulfate Proteoglycan Levels and Improves Motor Function Following Spinal Cord Injury","volume":"61","author":"McKillop","year":"2013","journal-title":"Glia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e195752","DOI":"10.1001\/jamanetworkopen.2019.5752","article-title":"Clinical and Molecular Characterization of PROM1-Related Retinal Degeneration","volume":"2","author":"Birtel","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"15955","DOI":"10.1073\/pnas.1920829117","article-title":"The Stem Cell Marker Prom1 Promotes Axon Regeneration by down-Regulating Cholesterol Synthesis via Smad Signaling","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","article-title":"Generation of Human Striatal Neurons by microRNA-Dependent Direct Conversion of Fibroblasts","volume":"84","author":"Victor","year":"2014","journal-title":"Neuron"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/1673-5374.169602","article-title":"Direct Reprogramming of Somatic Cells into Neural Stem Cells or Neurons for Neurological Disorders","volume":"11","author":"Hou","year":"2016","journal-title":"Neural Regen. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/hmg\/ddn440","article-title":"Dominant Cataract Formation in Association with a Vimentin Assembly Disrupting Mutation","volume":"18","author":"Bhattacharya","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2006.04.127","article-title":"Stem Cell Marker Expression in the Bergmann Glia Population of the Adult Mouse Brain","volume":"1099","author":"Sottile","year":"2006","journal-title":"Brain Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0896-6273(94)90042-6","article-title":"A Novel Role for Myelin-Associated Glycoprotein as an Inhibitor of Axonal Regeneration","volume":"13","author":"Mukhopadhyay","year":"1994","journal-title":"Neuron"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1471-4159.2006.04319.x","article-title":"Myelin-Associated Glycoprotein (MAG): Past, Present and Beyond","volume":"100","author":"Quarles","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1523\/JNEUROSCI.6239-09.2010","article-title":"MAG and OMgp Synergize with Nogo-A to Restrict Axonal Growth and Neurological Recovery after Spinal Cord Trauma","volume":"30","author":"Cafferty","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neuron.2010.05.002","article-title":"Assessing Spinal Axon Regeneration and Sprouting in Nogo-, MAG-, and OMgp-Deficient Mice","volume":"66","author":"Lee","year":"2010","journal-title":"Neuron"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0896-6273(95)90015-2","article-title":"Lack of Evidence That Myelin-Associated Glycoprotein Is a Major Inhibitor of Axonal Regeneration in the CNS","volume":"15","author":"Bartsch","year":"1995","journal-title":"Neuron"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2012.08.009","article-title":"An Essential Role of MAG in Mediating Axon-Myelin Attachment in Charcot-Marie-Tooth 1A Disease","volume":"49","author":"Kinter","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.5204-08.2009","article-title":"Axonal Protective Effects of the Myelin-Associated Glycoprotein","volume":"29","author":"Nguyen","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2013.06.008","article-title":"Accelerated Axon Loss in MOG35-55 Experimental Autoimmune Encephalomyelitis (EAE) in Myelin-Associated Glycoprotein-Deficient (MAGKO) Mice","volume":"262","author":"Jones","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.conb.2014.02.012","article-title":"Myelin-Associated Inhibitors in Axonal Growth after CNS Injury","volume":"27","author":"Geoffroy","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tcb.2012.06.001","article-title":"How Does Lin28 Let-7 Control Development and Disease?","volume":"22","author":"Thornton","year":"2012","journal-title":"Trends Cell Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s11064-014-1278-2","article-title":"LIN28 Expression in Rat Spinal Cord after Injury","volume":"39","author":"Yue","year":"2014","journal-title":"Neurochem. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ymthe.2020.04.010","article-title":"Upregulating Lin28a Promotes Axon Regeneration in Adult Mice with Optic Nerve and Spinal Cord Injury","volume":"28","author":"Nathan","year":"2020","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.celrep.2018.07.105","article-title":"Lin28 Signaling Supports Mammalian PNS and CNS Axon Regeneration","volume":"24","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1007\/s13277-015-4759-2","article-title":"Lin28: An Emerging Important Oncogene Connecting Several Aspects of Cancer","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1242\/dev.117580","article-title":"LIN28: Roles and Regulation in Development and Beyond","volume":"142","author":"Tsialikas","year":"2015","journal-title":"Development"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.V99.7.2369","article-title":"Notch1 Activation Increases Hematopoietic Stem Cell Self-Renewal in Vivo and Favors Lymphoid over Myeloid Lineage Outcome","volume":"99","author":"Stier","year":"2002","journal-title":"Blood"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood.V98.12.3283","article-title":"Notch1 Inhibits Differentiation of Hematopoietic Cells by Sustaining GATA-2 Expression","volume":"98","author":"Kumano","year":"2001","journal-title":"Blood"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.stem.2008.03.001","article-title":"Notch Signaling Activation in Human Embryonic Stem Cells Is Required for Embryonic, but Not Trophoblastic, Lineage Commitment","volume":"2","author":"Yu","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1016\/j.febslet.2005.10.047","article-title":"Rat Limbal Epithelial Side Population Cells Exhibit a Distinct Expression of Stem Cell Markers That Are Lacking in Side Population Cells from the Central Cornea","volume":"579","author":"Umemoto","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.neuron.2011.02.031","article-title":"Notch in the Vertebrate Nervous System: An Old Dog with New Tricks","volume":"69","author":"Pierfelice","year":"2011","journal-title":"Neuron"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuron.2011.01.004","article-title":"Activity-Induced Notch Signaling in Neurons Requires Arc\/Arg3.1 and Is Essential for Synaptic Plasticity in Hippocampal Networks","volume":"69","author":"Alberi","year":"2011","journal-title":"Neuron"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1242\/dev.129.2.373","article-title":"Notch1 Is Required for Neuronal and Glial Differentiation in the Cerebellum","volume":"129","author":"Radtke","year":"2002","journal-title":"Development"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuron.2011.11.017","article-title":"Notch Signaling Inhibits Axon Regeneration","volume":"73","author":"Hammarlund","year":"2012","journal-title":"Neuron"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnmol.2016.00033","article-title":"Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration","volume":"9","author":"Rao","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1460-9568.2005.04348.x","article-title":"Differential Expression of Cell Fate Determinants in Neurons and Glial Cells of Adult Mouse Spinal Cord after Compression Injury","volume":"22","author":"Chen","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1523\/JNEUROSCI.21-24-09814.2001","article-title":"Transcription Factor Expression and Notch-Dependent Regulation of Neural Progenitors in the Adult Rat Spinal Cord","volume":"21","author":"Yamamoto","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"45031","DOI":"10.1074\/jbc.M105245200","article-title":"Role of Deltex-1 as a Transcriptional Regulator Downstream of the Notch Receptor","volume":"276","author":"Yamamoto","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1523\/JNEUROSCI.17-21-08300.1997","article-title":"Expression of Neural RNA-Binding Proteins in the Postnatal CNS: Implications of Their Roles in Neuronal and Glial Cell Development","volume":"17","author":"Sakakibara","year":"1997","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/dbio.1996.0130","article-title":"Mouse-Musashi-1, a Neural RNA-Binding Protein Highly Enriched in the Mammalian CNS Stem Cell","volume":"176","author":"Sakakibara","year":"1996","journal-title":"Dev. Biol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000017435","article-title":"Musashi1: An Evolutionally Conserved Marker for CNS Progenitor Cells Including Neural Stem Cells","volume":"22","author":"Kaneko","year":"2000","journal-title":"Dev. Neurosci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1073\/pnas.232087499","article-title":"RNA-Binding Protein Musashi Family: Roles for CNS Stem Cells and a Subpopulation of Ependymal Cells Revealed by Targeted Disruption and Antisense Ablation","volume":"99","author":"Sakakibara","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.neuron.2010.07.005","article-title":"Neural RNA-Binding Protein Musashi1 Controls Midline Crossing of Precerebellar Neurons through Posttranscriptional Regulation of Robo3\/Rig-1 Expression","volume":"67","author":"Kuwako","year":"2010","journal-title":"Neuron"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fncel.2018.00045","article-title":"Musashi and Plasticity of Xenopus and Axolotl Spinal Cord Ependymal Cells","volume":"12","author":"Chernoff","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2011.07.009","article-title":"Axon Regeneration Pathways Identified by Systematic Genetic Screening in C. elegans","volume":"71","author":"Chen","year":"2011","journal-title":"Neuron"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1182\/blood.V90.12.5013","article-title":"A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular Cloning","volume":"90","author":"Miraglia","year":"1997","journal-title":"Blood"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1074\/jbc.275.8.5512","article-title":"The Human AC133 Hematopoietic Stem Cell Antigen Is Also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions","volume":"275","author":"Corbeil","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood.V90.12.5002","article-title":"AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells","volume":"90","author":"Yin","year":"1997","journal-title":"Blood"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.exphem.2016.07.006","article-title":"Tunneling Nanotubes Mediate the Transfer of Stem Cell Marker CD133 between Hematopoietic Progenitor Cells","volume":"44","author":"Reichert","year":"2016","journal-title":"Exp. Hematol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1523\/JNEUROSCI.2034-08.2009","article-title":"Loss of the Cholesterol-Binding Protein Prominin-1\/CD133 Causes Disk Dysmorphogenesis and Photoreceptor Degeneration","volume":"29","author":"Zacchigna","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1523\/JNEUROSCI.3363-12.2013","article-title":"Prominin-1 Allows Prospective Isolation of Neural Stem Cells from the Adult Murine Hippocampus","volume":"33","author":"Walker","year":"2013","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1167\/iovs.09-4857","article-title":"Autosomal Recessive Retinitis Pigmentosa with Early Macular Affectation Caused by Premature Truncation in PROM1","volume":"51","author":"Permanyer","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2162-3619-2-17","article-title":"CD133: A Stem Cell Biomarker and Beyond","volume":"2","author":"Li","year":"2013","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/ijmm.2012.1208","article-title":"CD133 Silencing Inhibits Stemness Properties and Enhances Chemoradiosensitivity in CD133-Positive Liver Cancer Stem Cells","volume":"31","author":"Lan","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.24005","article-title":"Neuronal Endoplasmic Reticulum Stress in Axon Injury and Neurodegeneration","volume":"74","author":"Li","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2013.02.013","article-title":"Ex-Vivo Expanded Human Blood-Derived CD133+ Cells Promote Repair of Injured Spinal Cord","volume":"328","author":"Kamei","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fncel.2020.00107","article-title":"Regeneration Through in Vivo Cell Fate Reprogramming for Neural Repair","volume":"14","author":"Tai","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Zhao, N., Francis, N.L., Calvelli, H.R., and Moghe, P.V. (2020). Microglia-Targeting Nanotherapeutics for Neurodegenerative Diseases. APL Bioeng., 4.","DOI":"10.1063\/5.0013178"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12264-022-01013-6","article-title":"Novel Microglia-Based Therapeutic Approaches to Neurodegenerative Disorders","volume":"39","author":"Zhang","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4155\/tde.11.16","article-title":"Perinatal Gene Delivery to the CNS","volume":"2","author":"Rahim","year":"2011","journal-title":"Ther. Deliv."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainresbull.2019.05.024","article-title":"Challenges of Gene Delivery to the Central Nervous System and the Growing Use of Biomaterial Vectors","volume":"150","author":"Puhl","year":"2019","journal-title":"Brain Res. Bull."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1292452","DOI":"10.3389\/fmed.2023.1292452","article-title":"Current Trends of Clinical Trials Involving CRISPR\/Cas Systems","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-020-0268-z","article-title":"The Clinical Potential of Gene Editing as a Tool to Engineer Cell-Based Therapeutics","volume":"9","author":"Fruhwirth","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 Gene Editing: New Hope for Alzheimer\u2019s Disease Therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref_190","unstructured":"(2023, December 05). The World\u2019s First CRISPR Therapy Is Approved: Who Will Receive It?. Available online: https:\/\/www.nature.com\/articles\/d41587-023-00016-6."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Mijanovi\u0107, O., Brankovi\u0107, A., Borovjagin, A.V., Butnaru, D.V., Bezrukov, E.A., Sukhanov, R.B., Shpichka, A., Timashev, P., and Ulasov, I. (2020). Battling Neurodegenerative Diseases with Adeno-Associated Virus-Based Approaches. Viruses, 12.","DOI":"10.3390\/v12040460"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fonc.2020.01387","article-title":"CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future","volume":"10","author":"Uddin","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/12\/3333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:20Z","timestamp":1760132420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/12\/3333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,17]]},"references-count":192,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["biomedicines11123333"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11123333","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,17]]}}}